BTIG Reiterates Buy on Connect Biopharma Hldgs, Maintains $10 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 74.8%

Neg 0% Neu 74.8% Pos 0%

BTIG analyst Julian Harrison reiterates Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy and maintains $10 price target.